Granisetron vs ondansetron: is it a question of duration of 5-HT(3) receptor blockade?

por Blower, P, Aapro, M
Publicado 2002

The incidence of anticipatory nausea and vomiting after repeat cycle chemotherapy: the effect of granisetron.

por Aapro, M. S., Kirchner, V., Terrey, J. P.
Publicado 1994

Effect of treatment with epoetin-β on survival, tumour progression and thromboembolic events in patients with cancer: an updated meta-analysis of 12 randomised controlled studies i...

por Aapro, M, Scherhag, A, Burger, H U
Publicado 2008

Clinical equivalence with G-CSF biosimilars: methodologic approach in a (neo)adjuvant setting in non-metastatic breast cancer

por Krendyukov, A., Schiestl, M., Höbel, N., Aapro, M.
Publicado 2017

Epoetin-β treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromb...

por Aapro, M, Osterwalder, B, Scherhag, A, Burger, H U
Publicado 2009

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer

por Aapro, M, Jelkmann, W, Constantinescu, S N, Leyland-Jones, B
Publicado 2012

Non-linearity of colony formation by human tumour cells from biopsy samples.

por Eliason, J. F., Aapro, M. S., Decrey, D., Brink-Petersen, M.
Publicado 1985

Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: a meta-analysis

por Aapro, M, Coiffier, B, Dunst, J, Österborg, A, Burger, H U
Publicado 2006

Organized breast cancer screening not only reduces mortality from breast cancer but also significantly decreases disability-adjusted life years: analysis of the Global Burden of Di...

por Molassiotis, A., Tyrovolas, S., Giné-Vázquez, I., Yeo, W., Aapro, M., Herrstedt, J.
Publicado 2021

Elective surgery for colorectal cancer in the aged: a clinical-economical evaluation.

por Audisio, R. A., Cazzaniga, M., Robertson, C., Veronesi, P., Andreoni, B., Aapro, M. S.
Publicado 1997

Integrated safety analysis of rolapitant with coadministered drugs from phase II/III trials: an assessment of CYP2D6 or BCRP inhibition by rolapitant

por Barbour, S., Smit, T., Wang, X., Powers, D., Arora, S., Kansra, V., Aapro, M., Herrstedt, J.
Publicado 2017

Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potential

por Roth, A D, Berney, C R, Rohner, S, Allal, A S, Morel, P, Marti, M-C, Aapro, M S, Alberto, P
Publicado 2000

The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

por Dranitsaris, G., Molassiotis, A., Clemons, M., Roeland, E., Schwartzberg, L., Dielenseger, P., Jordan, K., Young, A., Aapro, M.
Publicado 2017

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention...

por Zhang, L, Lu, S, Feng, J, Dechaphunkul, A, Chang, J, Wang, D, Chessari, S, Lanzarotti, C, Jordan, K, Aapro, M
Publicado 2018

Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives

por Aapro, M., Bossi, P., Dasari, A., Fallowfield, L., Gascón, P., Geller, M., Jordan, K., Kim, J., Martin, K., Porzig, S.
Publicado 2020

A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia

por Ludwig, Heinz, Aapro, M., Bokemeyer, C., Glaspy, J., Hedenus, M., Littlewood, T.J., Österborg, A., Rzychon, B., Mitchell, D., Beguin, Y.
Publicado 2014

Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study)

por Aapro, M., Ludwig, H., Bokemeyer, C., Gascón, P., Boccadoro, M., Denhaerynck, K., Krendyukov, A., Gorray, M., MacDonald, K., Abraham, I.
Publicado 2016

Supportive care in patients with cancer during the COVID-19 pandemic

por Aapro, M., Lyman, G.H., Bokemeyer, C., Rapoport, B.L., Mathieson, N., Koptelova, N., Cornes, P., Anderson, R., Gascón, P., Kuderer, N.M.
Publicado 2020

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and...

por Aapro, M., Rugo, H., Rossi, G., Rizzi, G., Borroni, M. E., Bondarenko, I., Sarosiek, T., Oprean, C., Cardona-Huerta, S., Lorusso, V., Karthaus, M., Schwartzberg, L., Grunberg, S.
Publicado 2014

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)(†)

por Cardoso, F., Costa, A., Norton, L., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Biganzoli, L., Blackwell, K. L., Cardoso, M. J., Cufer, T., El Saghir, N., Fallowfield, L., Fenech, D., Francis, P., Gelmon, K., Giordano, S. H., Gligorov, J., Goldhirsch, A., Harbeck, N., Houssami, N., Hudis, C., Kaufman, B., Krop, I., Kyriakides, S., Lin, U. N., Mayer, M., Merjaver, S. D., Nordström, E. B., Pagani, O., Partridge, A., Penault-Llorca, F., Piccart, M. J., Rugo, H., Sledge, G., Thomssen, C., van't Veer, L., Vorobiof, D., Vrieling, C., West, N., Xu, B., Winer, E.
Publicado 2014